Product Images Spironolactone

This is a description of Spironolactone tablets, USP having NDC 60687-487-01 distributed by American Health Packaging. Each film-coated tablet contains Spironolactone, USP 100 mg and the usual dose can be found in the package insert along with full prescribing information. The tablets should be stored between 20°C to 25°C (68°F to 77°F) and should be protected from light. The label warns against using the drug if it is found to be broken, and to keep it away from children.*

This appears to be a list of pharmaceuticals, specifically Spironolactone tablets in 25mg dosage, with various Lot numbers and codes.*

This is a description of Spironolactone Tablets USP, with NDC 60687-465-01. The package includes 100 tablets (10x10), and the medicine is only available with a prescription. Each film-coated tablet contains 25 mg of Spironolactone USP. Users are advised to follow the package insert for prescribing information and typical dosage. The tablets should be stored at controlled temperatures between 20-25°C. The medication should be kept away from children, and users are cautioned not to use if the blister is torn or broken. The package is distributed by Zydus Pharmaceuticals USA.*

This is a drug package containing 100 tablets of Spironolactone, USP which is used for various medical conditions. The usual dosage information is provided in the package insert. The tablets are film-coated and contain 50mg of Spironolactone, USP. It is recommended to store the tablets at controlled room temperature protected from light. The drug is Rx-only and should be kept out of reach of children. The package is distributed by American Health Packaging.*

This appears to be a report of a clinical trial comparing the effectiveness of Spironolactone versus placebo. The study included 822 participants in the Spironolactone group and 841 participants in the Placebo group. The log-rank p-value was less than 0.001, indicating a statistically significant difference between the two groups. The graph shows the number of months the study was conducted for.*

This is a table with various medical and demographic data concerning a subgroup of individuals. The data includes age, sex, race, heart failure, diabetes, kidney function, medication use, and other parameters. There is also a comparison between two treatments - Spironolactone and Placebo. However, there is not enough information to determine the full context or purpose of the table.*